11 companies

AddLife

Market Cap: SEK 19.2b

Provides instruments and equipment, consumables, and reagents primarily to medical care, research, colleges, and universities, as well as the food and pharmaceutical industries.

ALIF B

SEK 157.10

7D

2.6%

1Y

-20.1%

Bonesupport Holding

Market Cap: SEK 15.2b

An orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally.

BONEX

SEK 226.20

7D

2.2%

1Y

-13.5%

Swedencare

Market Cap: SEK 4.3b

Develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally.

SECARE

SEK 27.10

7D

-0.6%

1Y

-38.7%

Devyser Diagnostics

Market Cap: SEK 1.6b

Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.

DVYSR

SEK 90.40

7D

-5.2%

1Y

-22.1%

Cinclus Pharma Holding

Market Cap: SEK 559.4m

A clinical-stage pharmaceutical company, develops small molecules for the treatment of gastric acid-related diseases in China.

New

CINPHA

SEK 12.06

7D

0.3%

1Y

-31.9%

Mendus

Market Cap: SEK 317.8m

A biopharmaceutical company, develops immunotherapies for the treatment of myeloid blood cancers.

IMMU

SEK 5.17

7D

-0.2%

1Y

-20.3%

Promimic

Market Cap: SEK 198.4m

Engages in the manufacturing, marketing, and sale of biomaterials for improved osseointegration in the orthopedic and dental implants markets in Sweden.

PRO

SEK 10.50

7D

-11.0%

1Y

-47.5%

Diamyd Medical

Market Cap: SEK 174.8m

Develops precision medicine therapies for the treatment of autoimmune diabetes.

DMYD B

SEK 1.15

7D

2.9%

1Y

-88.9%

IDL Diagnostics

Market Cap: SEK 112.9m

A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.

New

IDLDX

SEK 0.48

7D

-2.9%

1Y

-12.5%

Alzinova

Market Cap: SEK 68.4m

A clinical-stage biopharma company, develops immunotherapies treatment for Alzheimer’s disease in Sweden.

ALZ

SEK 0.46

7D

-0.5%

1Y

-73.2%

PharmaLundensis

Market Cap: SEK 15.3m

PharmaLundensis AB operates as a pharmaceutical company.

PHAL

SEK 0.36

7D

0%

1Y

-44.6%